OX40 ligand
OX40 Ligand (also known as OX40L, CD252 or TNFSF4) is a protein that in humans is encoded by the TNFSF4 gene. It is a member of the tumor necrosis factor (TNF) ligand family and plays a crucial role in the immune system.
Function[edit]
The OX40 Ligand is primarily expressed on activated antigen-presenting cells (APCs) and binds to the OX40 receptor found on the surface of T cells. This interaction between OX40L and OX40 receptor is essential for T cell proliferation and survival, as well as for the generation of long-lived memory cells and immunological synapse formation.
Clinical Significance[edit]
The OX40-OX40L interaction has been implicated in several autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis (MS). It is also involved in allergic diseases such as asthma and atopic dermatitis. Therefore, OX40L has been a target for therapeutic intervention in these diseases.
Therapeutic Applications[edit]
Several therapeutic strategies have been developed to block the OX40-OX40L interaction, including the use of monoclonal antibodies, fusion proteins, and small molecule inhibitors. These therapies have shown promise in preclinical and early clinical trials for the treatment of autoimmune and allergic diseases.
See Also[edit]
- OX40
- Tumor necrosis factor
- Antigen-presenting cell
- T cell
- Memory cell
- Immunological synapse
- Autoimmune disease
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Multiple sclerosis
- Asthma
- Atopic dermatitis
- Monoclonal antibody
- Fusion protein
- Small molecule inhibitor
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian